Namwiwat Medical Corporation Public Company Limited

SET:NAM-R Stock Report

Market Cap: ฿3.2b

Namwiwat Medical Corporation Future Growth

Future criteria checks 3/6

Namwiwat Medical is forecast to grow earnings and revenue by 17.9% and 14.8% per annum respectively. EPS is expected to grow by 17.3% per annum. Return on equity is forecast to be 13.9% in 3 years.

Key information

17.9%

Earnings growth rate

17.3%

EPS growth rate

Medical Equipment earnings growth22.3%
Revenue growth rate14.8%
Future return on equity13.9%
Analyst coverage

Low

Last updated15 May 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SET:NAM-R - Analysts future estimates and past financials data (THB Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,440276-112841
12/31/20251,309241363291
12/31/20241,190212-342121
9/30/2024964174-3637N/A
6/30/2024936162-100-43N/A
3/31/20241,00816877135N/A
12/31/20231,103201220259N/A
9/30/20231,239242149158N/A
12/31/20221,100176-135-81N/A
12/31/20219951759394N/A
12/31/2020679112104105N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NAM-R's forecast earnings growth (17.9% per year) is above the savings rate (2%).

Earnings vs Market: NAM-R's earnings (17.9% per year) are forecast to grow faster than the TH market (16.7% per year).

High Growth Earnings: NAM-R's earnings are forecast to grow, but not significantly.

Revenue vs Market: NAM-R's revenue (14.8% per year) is forecast to grow faster than the TH market (6.5% per year).

High Growth Revenue: NAM-R's revenue (14.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NAM-R's Return on Equity is forecast to be low in 3 years time (13.9%).


Discover growth companies